Targeted drug delivery

From Wikipedia, the free encyclopedia

This article or section is in need of attention from an expert on the subject.
Please help recruit one or improve this article yourself. See the talk page for details.
Please consider using {{Expert-subject}} to associate this request with a WikiProject

The tone or style of this article or section may not be appropriate for Wikipedia.
Specific concerns may be found on the talk page. See Wikipedia's guide to writing better articles for suggestions.(March 2008)

Scientists began to study targeted drug delivery, because the traditional drug delivery system had many disadvantages, such as high toxic effect and high minimum effective dose. In traditional drug delivery system, after the patient takes some drugs, the drugs will be all over his body through the blood circulation. Only a small amount of drugs can arrive at the position where there is a sickness. Since many drugs have some toxicity, they can kill some helpful bacteria or normal cells in some normal organs.

The targeted drug delivery system can overcome these shortcomings and deliver the drugs right to the target, without hurting normal organs and tissues. Actually, the targeted drug delivery can be used to cure many diseases, such as the cardiovascular diseases and diabetes. However, the most important application of the targeted drug delivery is to treat the cancerous tumor.

There are two kinds of targeted drug delivery. The first one is active targeted drug delivery, such as some antibody drugs. The second one is passive targeted drug delivery, such as the Enhanced Permeability and Retention effect (EFR-effect).